Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for <i>Helicobacter pylori</i> eradication: a randomised trial

Abstract

In an area with >15% prevalence of clarithromycin resistant H pylori strains, a levofloxacin containing sequential therapy is more effective, equally safe and cost-saving compared to a clarithromycin containing sequential therapy.